Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 4Neoplasms 2Multiple Myeloma 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Prostate Cancer Metastatic 1Ovarian Neoplasms 1Neutropenia 1Lymphoma, B-Cell 1Hodgkin Disease 1Endodermal Sinus Tumor 1Central Nervous System Neoplasms 1Castrate Resistant Prostate Cancer 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 92Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 52Doxorubicin 50trametinib 47atezolizumab 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Lenograstim × Clear all
NCT06145321 2024-09-19

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

Chang Gung Memorial Hospital

Phase 4 Active not recruiting
20 enrolled

Neoplasms, Neutropenia

NCT01107756 2012-10-05

Grano-Tax

Sanofi

Phase 4 Completed
403 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡